Prescription drug · ANDA
EnilloRing NDC 70700-156
etonogestrel and ethinyl estradiol vaginal · Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d · Ring · Vaginal · Xiromed, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70700-156-91 | 7070001569170700015691 | 3 POUCH in 1 CARTON (70700-156-91) / 21 d in 1 POUCH (70700-156-11)Marketed from Aug 15, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- EnilloRing
- Generic name (nonproprietary)
- etonogestrel and ethinyl estradiol vaginal
- Active ingredients
- Ethinyl estradiol — .015 mg/dEtonogestrel — .12 mg/d
- Dosage form
- Ring
- Route
- Vaginal
- Labeler
- Xiromed, LLCNDC labeler code 70700
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211157
- Marketing start
- Listing expires
- Other FDA classes
- Estrogen Receptor Agonists (Mechanism)Progesterone Congeners (Chemical structure)
- Identifiers
- Product ID 70700-156_fdcf9082-3f49-2942-cc4b-d92d88df2dbcSPL ID fdcf9082-3f49-2942-cc4b-d92d88df2dbcSPL set ID 85a126f6-d3e0-9e12-73f9-6176ba36f58bRxCUI 1367436, 2644707UNII 423D2T571U, 304GTH6RNHUPC 0370700156919
- Pharmacologic class
- Estrogen; Progestin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N470700015691followed by a unit qualifier and the quantityPackage 70700-0156-91. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
FOR VAGINAL USE ONLY EnilloRing is indicated for use by females of reproductive age to prevent pregnancy. EnilloRing is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 70700-156
- What is NDC 70700-156?
- 70700-156 is the product NDC for EnilloRing, Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d ring, listed with the FDA by Xiromed, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- EnilloRing (Etonogestrel and Ethinyl Estradiol Vaginal).
- What is the active ingredient?
- Ethinyl estradiol, Etonogestrel.
- Who is the labeler?
- Xiromed, LLC, NDC labeler code 70700. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for EnilloRing?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 211157
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Etonogestrel and Ethinyl Estradiol Vaginal | Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d | RingVaginal | AvKARE | 42291-478 |
| Etonogestrel and Ethinyl Estradiol Vaginal Ring | Ethinyl estradiol .015 mg/d; Etonogestrel .12 mg/d | RingVaginal | Northstar Rx LLC | 16714-029 |